Carsgen Therapeutics Holding Ownership
HK$12.55
2.03%
Hong Kong, Sep 18, 03:46 pm HKT.
Closed.
ISIN
KYG1996C1006
Symbol
2171
Industry
Carsgen Therapeutics Holding Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
YIJIE Biotech Holding Ltd
|
198.140m | 34.74% | — | Apr 23 2026 |
| 2 |
Yang (Xuehong)
|
8.889m | 1.56% | — | Dec 31 2025 |
| 3 |
The Vanguard Group, Inc.
|
6.360m | 1.12% | -5.424m | Apr 30 2026 |
| 4 |
Guo (Xiaojing)
|
5.556m | 0.97% | — | Apr 23 2026 |
| 5 |
Norges Bank Investment Management (NBIM)
|
3.869m | 0.68% | -2.351m | Dec 31 2025 |
|
1
YIJIE Biotech Holding Ltd
|
34.74%
198.140m
|
|
2
Yang (Xuehong)
|
1.56%
8.889m
|
|
3
The Vanguard Group, Inc.
|
1.12%
6.360m
|
|
4
Guo (Xiaojing)
|
0.97%
5.556m
|
|
5
Norges Bank Investment Management (NBIM)
|
0.68%
3.869m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 39.07% of Carsgen Therapeutics Holding, with YIJIE Biotech Holding Ltd the biggest at 34.74%, followed by Yang (Xuehong) (1.56%) and The Vanguard Group, Inc. (1.12%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
